FDA Inspection 865086 — Allergan
The FDA completed an inspection of Allergan on February 6, 2014 in Goleta, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 6, 2014
- Fiscal Year
- 2014
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Goleta, CA (United States)
Additional Details
Postmarket Audit Inspections